Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
País/Região como assunto
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Endocrinol Metab (Seoul) ; 34(1): 53-62, 2019 03.
Artigo em Inglês | MEDLINE | ID: mdl-30912339

RESUMO

The Korean Endocrine Society (KES) published clinical practice guidelines for the treatment of acromegaly in 2011. Since then, the number of acromegaly cases, publications on studies addressing medical treatment of acromegaly, and demands for improvements in insurance coverage have been dramatically increasing. In 2017, the KES Committee of Health Insurance decided to publish a position statement regarding the use of somatostatin analogues in acromegaly. Accordingly, consensus opinions for the position statement were collected after intensive review of the relevant literature and discussions among experts affiliated with the KES, and the Korean Neuroendocrine Study Group. This position statement includes the characteristics, indications, dose, interval (including extended dose interval in case of lanreotide autogel), switching and preoperative use of somatostatin analogues in medical treatment of acromegaly. The recommended approach is based on the expert opinions in case of insufficient clinical evidence, and where discrepancies among the expert opinions were found, the experts voted to determine the recommended approach.


Assuntos
Acromegalia/tratamento farmacológico , Neuroendocrinologia/organização & administração , Somatostatina/análogos & derivados , Acromegalia/complicações , Acromegalia/epidemiologia , Acromegalia/fisiopatologia , Acromegalia/cirurgia , Antineoplásicos/administração & dosagem , Antineoplásicos/uso terapêutico , Antineoplásicos Hormonais/administração & dosagem , Antineoplásicos Hormonais/uso terapêutico , Atitude , Consenso , Tomada de Decisões , Prova Pericial/métodos , Humanos , Injeções Intramusculares , Seguro Saúde/normas , Octreotida/administração & dosagem , Octreotida/uso terapêutico , Peptídeos Cíclicos/administração & dosagem , Peptídeos Cíclicos/uso terapêutico , Guias de Prática Clínica como Assunto , Período Pré-Operatório , República da Coreia/epidemiologia , Somatostatina/administração & dosagem , Somatostatina/uso terapêutico
2.
Eur J Cancer Prev ; 28(4): 344-349, 2019 07.
Artigo em Inglês | MEDLINE | ID: mdl-30362975

RESUMO

Previous epidemiological studies have reported persistent organic pollutants (POPs) and some nonpersistent pesticides and the risk of thyroid cancer. The aim of this study was to assess the association between exposure to POPs, pesticides, and thyroid cancer by carrying out a meta-analysis. Literature searches were performed using PubMed, Embase, and reference lists of relevant articles. Summary risk estimates for thyroid cancer were calculated using fixed-effects and random-effects models. In addition, several subgroup and sensitivity analyses were carried out. Fifteen studies were reviewed, and eight studies were included in the meta-analysis. Pesticide exposure showed positive, statistically significant associations with thyroid cancer [odds ratio (OR)=1.48, 95% confidence interval (CI)=1.15-1.91, I=48%, Pheterogenetiy=0.05]. After subgroup analysis, herbicide exposure (OR=3.00, 95% CI=1.38-6.54) and agricultural exposure to pesticides (OR=1.86, 95% CI=1.04-3.32) was associated with an increased risk of thyroid cancer. A sensitivity analysis showed that the results were robust. Exposure to pesticides was associated with an increased risk of thyroid cancer in this meta-analysis. Future studies should investigate exposure to POPs or pesticides with controls for potential confounders using biological samples.


Assuntos
Exposição Ambiental/efeitos adversos , Poluentes Ambientais/toxicidade , Compostos Orgânicos/toxicidade , Praguicidas/toxicidade , Neoplasias da Glândula Tireoide/epidemiologia , Fatores de Confusão Epidemiológicos , Exposição Ambiental/prevenção & controle , Carga Global da Doença , Humanos , Incidência , Razão de Chances , Fatores de Risco , Neoplasias da Glândula Tireoide/etiologia , Neoplasias da Glândula Tireoide/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA